Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,518,664
+$342,242 QoQ
Shares Held
10,009
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,779
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KLCM Advisors, Inc. holds $30,076,760 across 9 Drug Manufacturers - General names. ABBV ranks #3 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
293,739 | $16,925,241 | |
| 2 | PFE |
Pfizer Inc
|
166,401 | $4,006,936 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
10,009 | $2,518,664 | |
| 4 | JNJ |
Johnson & Johnson
|
8,607 | $2,185,919 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,218 | $1,698,513 | |
| 6 | LLY |
ELI LILLY & Co
|
1,147 | $1,375,746 | |
| 7 | OGN |
Organon & Co.
|
48,807 | $660,846 | |
| 8 | AMGN |
Amgen Inc
|
1,343 | $486,327 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,518,664 | 10,009 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,176,422 | 10,007 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,169,055 | 9,493 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,197,546 | 9,491 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,806,268 | 9,731 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,092,266 | 9,986 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,872,602 | 10,538 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,116,985 | 10,720 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,878,753 | 22,614 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,459,446 | 24,489 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $3,875,334 | 25,007 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $3,764,510 | 25,255 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,236,349 | 24,021 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,695,218 | 10,637 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,647,290 | 10,193 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,377,263 | 10,262 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,401,720 | 9,152 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,189,725 | 7,339 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $993,700 | 7,339 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $901,685 | 8,359 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $984,248 | 8,738 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,049,192 | 9,695 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $1,017,389 | 9,495 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $834,294 | 9,525 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $931,728 | 9,490 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $723,043 | 9,490 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||